Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA Approves Ozempic
December 5, 2017 -- Novo Nordisk today announced that the U.
CVS Health, Aetna to merge
CVS Health and Aetna on Sunday announced their plan to merge.
Amneal launches Clolar generic
Amneal’s biosciences arm recently introduced its generic of Clolar (clofarabine, 1mg/ml).
FDA approves Breckenridge’s Megace ES generic
The Food and Drug Administration has approved Breckenridge Pharmaceuticals’ generic of Megace ES (megestrol acetate oral suspension).
Mylan, Aspen launch generic Myleran
Mylan is launching its latest generic with its partner, South Africa-based Aspen.
Trouble mounts for Sanofi dengue vaccine over safety concerns
(Reuters) - The World Health Organization said on Monday it hopes to review safety data on Sanofi’s dengue vaccine this month, while the Philippines ordered an investigation of its now suspe...
AbbVie’s IL-23 blocker shows efficacy in psoriasis trial
An experimental therapy being developed by AbbVie for the treatment of patients with moderate to severe plaque psoriasis has hit key targets in a pivotal late-stage trial.
BRIEF—Gilead announces public health initiative to combat HIV/AIDS in southern USA
Gilead Sciences has announced the launch of a 10-year, $100 million commitment to support organizations combatting the HIV/AIDS epidemic in the Southern United States.
Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS
Active Biotech (Nasdaq Stockholm.
Researchers identify medication that can prevent migraines
An antibody therapy against key inflammatory molecule involved in migraines reduces the number of headaches in chronic migraine patients.
Astellas buys DMD drug in $450M mitochondrial takeover
Astellas has acquired its partner Mitobridge in a deal worth up to $450 million.
Preventing psoriasis with vanillin
Small amounts of artificial vanilla extract, also known as vanillin, are in a wide range of products, from baked goods to perfumes.
519
520
521
522
523
524
525
526
527
